Meet Jackie Hunter, CEO BenevolentBio and more than 500 healthcare, pharmaceutical and technology influencers and leaders at the fifth annual WIRED Health event in London.
In 2016, total expenditure on prescription drugs in the US was estimated at $450 billion. During this year, almost half of the US population took at least one prescription medicine every month. It is essential that we find ways to streamline this process, removing inefficencies and unnecessary costs, while bringing efficacious prescription drugs to the population as soon as possible. We believe that Artificial Intelligence offers the best solutions to solve these issues.
The 5th annual Advanced Pharma Analytics Europe Summit 2018 is dedicated to bringing together Data Science and Advanced Analytics leaders to address the biggest challenges and opportunities in this space.
Join Ian Churcher, VP of Drug Discovery at BenevolentBio as he discusses Targeted Protein Degradation, one of the most exciting and fast growing areas of drug discovery. Ian will give an introduction to the area and highlight how AI approaches can be used to accelerate progress.
Jackie Hunter, CEO BenevolentAI is presenting at JP Morgan Healthcare Conference on the future of Pharma.
Join Jackie Hunter, CEO BenevolentBio who will share her thoughts and her experience.
Join Mark Davies, VP Biomedical Informatics at BenevolentAI for a talk on "Disrupting Drug Discovery with AI"
Join Rabia T. Khan, Exploratory Scientist at BenevolentAI for a panel discussion on What makes a great researcher: tools and skills.
Join Patrick Keohane, CMO at BenevolentAI for a panel on Disruption from Afar: Embracing New Non-Pharma Technologies & Actors
Jackie Hunter, CEO BenevolentBio and Jerome Pesenti, CEO BenevolentTech will be joining Web Summit this year.
Patrick Keohane, Chied Medical Officer at BenevolentBio will be presenting at the BioData World Congress 2017
Jerome Pesenti, CEO at BenevolentTech will be joining Data Driven Event held at Bloomberg LP to discuss how BenevolentAI artificial intelligence can accelerate drug discovery
Big Data is the process of analysing high volume, high velocity data by advanced computational methods that produce actionable knowledge...
Amir Saffari, Director of Applied AI will be discussing Machine Learning for Drug Discovery - Join the event
Translating UK scientific excellence in global therapeutics strategies
Meet Jérôme Pesenti, CEO BenevolentTech at Viva Technology in Paris
Join a select group of 250 practitioners, researchers, entrepreneurs and investors to explore current and future industry applications of groundbreaking new technologies in healthcare.
Making science personal. Bringing together big pharma, big data and healthcare providers.
To identify issues and discuss potential solutions around achieving best care and treatment for all patients with breast cancer
Join Professor Jackie Hunter who will present on “AI and Biomedicine: Culture clash or marriage made in heaven".
with Professor Jackie Hunter, CEO at Stratified Medical, a BenevolentAI company
Internal Talk at BenevolentAI